Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 201,606	$ 213,022
Accounts receivable, net	56,393	72,725
Inventories, net	144,609	178,688
Income taxes receivable	1,559	2,261
Derivative financial instruments	38,298	16,423
Other current assets	17,464	25,795
Total current assets	459,929	508,914
Property, plant and equipment, net	398,599	473,960
Deferred income tax assets, net	52,213	35,187
Intangibles, net	33,242	51,497
Derivative financial instruments	40,471	18,537
Other non-current assets	46,117	45,644
Total assets	1,030,571	1,133,739
Current liabilities:
Accounts payable	124,907	158,049
Short-term debt	5,322	5,873
Accrued expenses	66,838	74,108
Income taxes payable	1,844	13,300
Total current liabilities	198,911	251,330
Long-term debt (less current portion)	610,632	616,145
Non-current income tax liabilities	8,129	8,524
Deferred income tax liabilities, net	1,903	3,468
Other non-current liabilities	47,821	55,733
Commitments and contingent liabilities (Note 19)
Mezzanine equity:
Preferred stock, $0.01 par value Authorized - 1,000,000 shares Issued and outstanding 150,000 shares outstanding at December 31, 2023 and December 31, 2022	248,222	222,753
European non-controlling redeemable equity	893	1,083
Shareholders’ deficit:
Common stock, $0.01 par value Authorized - 100,000,000 shares Issued and outstanding 28,091,440 and 27,016,125 shares at December 31, 2023 and December 31, 2022	115,340	111,105
Accumulated other comprehensive loss	(22,291)	(89,269)
Retained earnings	(178,989)	(47,133)
Total shareholders’ deficit	(85,940)	(25,297)
Total liabilities, mezzanine equity and shareholders’ deficit	$ 1,030,571	$ 1,133,739